{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:16:02Z","timestamp":1790630162608,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"SOBI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chemocentryx and Novimmune"},{"name":"GOSH Children\u2019s Charity"},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"SOBI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ReMission"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/rheumatology\/key445","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T21:07:08Z","timestamp":1545426428000},"page":"1227-1238","source":"Crossref","is-referenced-by-count":55,"title":["Monogenic mimics of Beh\u00e7et\u2019s disease in the young"],"prefix":"10.1093","volume":"58","author":[{"given":"C","family":"Papadopoulou","sequence":"first","affiliation":[{"name":"Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK"},{"name":"Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Omoyinmi","sequence":"additional","affiliation":[{"name":"Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK"},{"name":"Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Standing","sequence":"additional","affiliation":[{"name":"Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK"},{"name":"Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Pain","sequence":"additional","affiliation":[{"name":"Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Booth","sequence":"additional","affiliation":[{"name":"Infection, Immunity, Inflammation, Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"D\u2019Arco","sequence":"additional","affiliation":[{"name":"Neuroradiology, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Immunology, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Buckland","sequence":"additional","affiliation":[{"name":"Immunology, Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Eleftheriou","sequence":"additional","affiliation":[{"name":"Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK"},{"name":"Great Ormond Street Hospital NHS Foundation Trust, London, UK"},{"name":"Arthritis Research UK Centre for Adolescent Rheumatology, UCL, UCLH and GOSH, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Brogan","sequence":"additional","affiliation":[{"name":"Infection, Inflammation and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, UK"},{"name":"Great Ormond Street Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"2019062109405507800_key445-B1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.24423","article-title":"Epidemiology and clinical characteristics of Behcet's disease in the US: a population-based study","volume":"61","author":"Calamia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2019062109405507800_key445-B2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Behcet's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2019062109405507800_key445-B3","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","article-title":"Paediatric Behcet's disease: a UK tertiary centre experience","volume":"35","author":"Nanthapisal","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2019062109405507800_key445-B4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"2019062109405507800_key445-B5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","article-title":"Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet's disease: an international cohort study of 110 patients. One-year follow-up data","volume":"50","author":"Kone-Paut","year":"2011","journal-title":"Rheumatology"},{"key":"2019062109405507800_key445-B6","first-page":"912589","article-title":"Genetics of Behcet's disease","volume":"2012","author":"Kaya","year":"2012","journal-title":"Patholog Res Int"},{"key":"2019062109405507800_key445-B7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","article-title":"Behcet's disease in children, an overview","volume":"14","author":"Kone-Paut","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2019062109405507800_key445-B8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat Genet"},{"key":"2019062109405507800_key445-B9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.3786","article-title":"Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility","volume":"49","author":"Takeuchi","year":"2017","journal-title":"Nat Genet"},{"key":"2019062109405507800_key445-B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaut.2015.08.013","article-title":"The immunogenetics of Behcet's disease: a comprehensive review","volume":"64","author":"Takeuchi","year":"2015","journal-title":"J Autoimmun"},{"key":"2019062109405507800_key445-B11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"2019062109405507800_key445-B12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"2019062109405507800_key445-B13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2019062109405507800_key445-B14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: pEDBD","volume":"75","author":"Kone-Paut","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2019062109405507800_key445-B15","doi-asserted-by":"crossref","first-page":"e0181874","DOI":"10.1371\/journal.pone.0181874","article-title":"Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis","volume":"12","author":"Omoyinmi","year":"2017","journal-title":"PLoS One"},{"key":"2019062109405507800_key445-B16","article-title":"Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics","author":"Wallis","year":"2013"},{"key":"2019062109405507800_key445-B17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2019062109405507800_key445-B18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1","volume":"214","author":"Standing","year":"2017","journal-title":"J Exp Med"},{"key":"2019062109405507800_key445-B19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2249.2006.03138.x","article-title":"Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists","volume":"145","author":"de Vries","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2019062109405507800_key445-B20","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1073\/pnas.88.7.2753","article-title":"Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat","volume":"88","author":"Casimir","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019062109405507800_key445-B21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.24573","article-title":"Chronic granulomatous disease: clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients","volume":"92","author":"Wolach","year":"2017","journal-title":"Am J Hematol"},{"key":"2019062109405507800_key445-B22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-3083.2012.02771.x","article-title":"Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease","volume":"76","author":"Jakobsen","year":"2012","journal-title":"Scand J Immunol"},{"key":"2019062109405507800_key445-B23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2019062109405507800_key445-B24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Hum Genomics"},{"key":"2019062109405507800_key445-B25","first-page":"615218","article-title":"Fabry disease and early stroke","volume":"2011","author":"Feldt-Rasmussen","year":"2011","journal-title":"Stroke Res Treat"},{"key":"2019062109405507800_key445-B26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10545-010-9261-9","article-title":"Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group","volume":"34","author":"Gal","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"2019062109405507800_key445-B27","doi-asserted-by":"crossref","first-page":"O25","DOI":"10.1186\/1546-0096-12-S1-O25","article-title":"A de novo nonsense mutation in the tyrosine kinase Lyn in a patient with an early onset autoinflammatory phenotype","volume":"12","author":"De Jesus","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"2019062109405507800_key445-B28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2012-10-463158","article-title":"Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling","volume":"122","author":"Slavova-Azmanova","year":"2013","journal-title":"Blood"},{"key":"2019062109405507800_key445-B29","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20020515","article-title":"Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity","volume":"196","author":"Hibbs","year":"2002","journal-title":"J Exp Med"},{"key":"2019062109405507800_key445-B30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2008.11.041","article-title":"Signal transducer and activator of transcription 5 tyrosine phosphorylation for the diagnosis and monitoring of patients with severe combined immunodeficiency","volume":"123","author":"Walshe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2019062109405507800_key445-B31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2019062109405507800_key445-B32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2019062109405507800_key445-B33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-811X-10-21","article-title":"Functions of the Lyn tyrosine kinase in health and disease","volume":"10","author":"Ingley","year":"2012","journal-title":"Cell Commun Signal"},{"key":"2019062109405507800_key445-B34","doi-asserted-by":"crossref","first-page":"O25","DOI":"10.1186\/1546-0096-12-S1-O25","article-title":"A de novo nonsense mutation in the tyrosine kinase Lyn in a patient with an early onset autoinflammatory phenotype","volume":"12","author":"Almeida De Jesus","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"2019062109405507800_key445-B35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J Cell Biol"},{"key":"2019062109405507800_key445-B36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"key":"2019062109405507800_key445-B37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol Genet Metab"},{"key":"2019062109405507800_key445-B38","doi-asserted-by":"crossref","first-page":"87782","DOI":"10.1515\/jpem-2013-0062","article-title":"Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome","volume":"26","author":"Senniappan","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019062109405507800_key445-B39","doi-asserted-by":"crossref","first-page":"e20163148","DOI":"10.1542\/peds.2016-3148","article-title":"Tocilizumab for the treatment of SLC29A3 mutation positive PHID syndrome","volume":"140","author":"Rafiq","year":"2017","journal-title":"Pediatrics"},{"key":"2019062109405507800_key445-B40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2009.02.319","article-title":"Thrombosis in Japanese patients with Fabry disease","volume":"283","author":"Utsumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"2019062109405507800_key445-B41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000001333","article-title":"Thromboembolic events in Fabry disease and the impact of factor V Leiden","volume":"84","author":"Lenders","year":"2015","journal-title":"Neurology"},{"key":"2019062109405507800_key445-B42","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"2019062109405507800_key445-B43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"2019062109405507800_key445-B44","first-page":"S35","article-title":"MEFV mutations are increased in Behcet's disease (BD) and are associated with vascular involvement","volume":"21","author":"Atagunduz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2019062109405507800_key445-B45","doi-asserted-by":"crossref","first-page":"e0132704","DOI":"10.1371\/journal.pone.0132704","article-title":"Association between MEFV mutations M694V and M680I and Behcet's disease: a meta-analysis","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"2019062109405507800_key445-B46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13256-017-1552-4","article-title":"A novel single variant in the MEFV gene causing Mediterranean fever and Behcet's disease: a case report","volume":"12","author":"Zerkaoui","year":"2018","journal-title":"J Med Case Rep"},{"key":"2019062109405507800_key445-B47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/humu.10103","article-title":"I591T MEFV mutation in a Spanish kindred: is it a mild mutation, a benign polymorphism, or a variant influenced by another modifier?","volume":"20","author":"Aldea","year":"2002","journal-title":"Hum Mutat"},{"key":"2019062109405507800_key445-B48","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2004.030379","article-title":"Colchicine responsive periodic fever syndrome associated with pyrin I591T","volume":"64","author":"Fisher","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2019062109405507800_key445-B49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00439-012-1250-7","article-title":"TNFAIP3 gene polymorphisms confer risk for Behcet's disease in a Chinese Han population","volume":"132","author":"Li","year":"2013","journal-title":"Hum Genet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/7\/1227\/28852812\/key445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T16:29:36Z","timestamp":1589992176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/7\/1227\/5304695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,1,30]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key445","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,1,30]]}}}